Your browser doesn't support javascript.
loading
Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.
Déry, Jean-Pierre; Mahaffey, Kenneth W; Tricoci, Pierluigi; White, Harvey D; Podder, Mohua; Westerhout, Cynthia M; Moliterno, David J; Harrington, Robert A; Chen, Edmond; Strony, John; Van de Werf, Frans; Ziada, Khaled M; Held, Claes; Aylward, Philip E; Armstrong, Paul W; Rao, Sunil V.
Afiliação
  • Déry JP; Department of Cardiology and Cardiovascular Surgery, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Laval University, Quebec City, Canada.
  • Mahaffey KW; Department of Medicine, Department of Medicine, Stanford University, Stanford, California.
  • Tricoci P; Department of Medicine, Duke Clinical Research Institute, Durham, North Carolina.
  • White HD; Department of Cardiology, Green Lane Cardiovascular Service, Auckland, New Zealand.
  • Podder M; Department of Economics, Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
  • Westerhout CM; Department of Economics, Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
  • Moliterno DJ; Department of Internal Medicine, Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky.
  • Harrington RA; Department of Medicine, Department of Medicine, Stanford University, Stanford, California.
  • Chen E; Bayer HealthCare Pharmaceuticals, Department of Internal Medicine, Bayer HealthCare Pharmaceuticals, Whippany, New Jersey.
  • Strony J; Merck, Whitehouse Station, New Jersey.
  • Van de Werf F; Department of Cardiovascular Sciences, University Hospitals Leuven, Belgium.
  • Ziada KM; Department of Internal Medicine, Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky.
  • Held C; Department of Medical Sciences, Uppsala Clinical Research Center, Uppsala University, Sweden.
  • Aylward PE; Division of Medicine, SAHMRI, Flinders University and Medical Center, Adelaide, Australia.
  • Armstrong PW; Department of Economics, Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
  • Rao SV; Department of Medicine, Duke Clinical Research Institute, Durham, North Carolina.
Catheter Cardiovasc Interv ; 88(2): 163-73, 2016 Aug.
Article em En | MEDLINE | ID: mdl-26698636

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Cateterismo Periférico / Inibidores da Agregação Plaquetária / Artéria Radial / Síndrome Coronariana Aguda / Artéria Femoral / Intervenção Coronária Percutânea / Lactonas Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Catheter Cardiovasc Interv Assunto da revista: CARDIOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Cateterismo Periférico / Inibidores da Agregação Plaquetária / Artéria Radial / Síndrome Coronariana Aguda / Artéria Femoral / Intervenção Coronária Percutânea / Lactonas Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Catheter Cardiovasc Interv Assunto da revista: CARDIOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos